The presence of non-organ-specific autoantibodies is associated with a negative response to combination therapy with interferon and ribavirin for chronic hepatitis C (Q24801439)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The presence of non-organ-specific autoantibodies is associated with a negative response to combination therapy with interferon and ribavirin for chronic hepatitis C	scientific article

Statements

scholarly article

0 references

The presence of non-organ-specific autoantibodies is associated with a negative response to combination therapy with interferon and ribavirin for chronic hepatitis C (English)

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

author name string

Hermann E Wasmuth

1

0 references

Christian Stolte

2

0 references

Andreas Geier

3

0 references

Christoph G Dietrich

4

0 references

Carsten Gartung

5

0 references

Johann Lorenzen

6

0 references

Siegfried Matern

7

0 references

Frank Lammert

8

0 references

language of work or name

0 references

publication date

13 February 2004

0 references

BMC Infectious Diseases

0 references

4

0 references

1

0 references

4

0 references

Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=373450

7 April 2017

Autoantibodies and autoantigens in autoimmune hepatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=373450

28 September 2017

Autoimmune hepatitis: diagnostic criteria, subclassifications, and clinical features

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=373450

28 September 2017

Autoimmunity and extrahepatic manifestations in hepatitis C virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=373450

28 September 2017

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=373450

28 September 2017

Auto-antibodies in hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=373450

28 September 2017

Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=373450

28 September 2017

Autoantibodies before, during and after administration of recombinant interferon-alpha for chronic viral hepatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=373450

28 September 2017

Immunomorphological characterisation of antinuclear antibodies in chronic liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=373450

28 September 2017

Classification of smooth muscle autoantibodies detected by immunofluorescence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=373450

28 September 2017

Antimitochondrial antibodies in patients with chronic hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=373450

30 May 2018

Chronic hepatitis. An update on terminology and reporting.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=373450

30 May 2018

Ribavirin enhancement of hepatitis C virus core antigen-specific type 1 T helper cell response correlates with the increased IL-12 level

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-4-4

21 January 2018

Ribavirin polarizes human T cell responses towards a Type 1 cytokine profile.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-4-4

21 January 2018

Interleukin-12 p40/p70 ratio and in vivo responsiveness to IFN-alpha treatment in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-4-4

21 January 2018

Ribavirin enhances interferon-gamma levels in patients with chronic hepatitis C treated with interferon-alpha.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-4-4

21 January 2018

Increased incidence of anti-LKM autoantibodies in a consecutive cohort of hepatitis C patients from central Greece

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-4-4

21 January 2018

Expression and clinical significance of antinuclear antibody in hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-4-4

21 January 2018

Prevalence of non-organ specific autoantibodies in HCV-infected subjects in the general population

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-4-4

21 January 2018

The addition of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-4-4

21 January 2018

Definition and classification of autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-4-4

21 January 2018

Variant syndromes of autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-4-4

21 January 2018

A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=373450

28 November 2018

Induction of antinuclear antibody after interferon therapy in patients with type-C chronic hepatitis: its relation to the efficacy of therapy

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-4-4

21 January 2018

National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C 2002 (June 10-12, 2002)

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-4-4

21 January 2018

Anti-neutrophil antibodies in chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-4-4

21 January 2018

Does the presence of serum autoantibodies influence the responsiveness to interferon-alpha 2a treatment in chronic hepatitis C?

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-4-4

21 January 2018

[Autoantibodies in chronic hepatitis C. Markers of autoimmunity or non-specific events?]

1 reference

https://pubmed.ncbi.nlm.nih.gov/15040810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2334-4-4

0 references

Dimensions Publication ID

0 references

0 references

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24801439&oldid=2176938533"